Sütö G, Király A, Taché Y
Center for Ulcer Research, Veterans Administration Wadsworth Medical Center, Los Angeles, California.
Gastroenterology. 1994 Jun;106(6):1568-75. doi: 10.1016/0016-5085(94)90412-x.
BACKGROUND/AIMS: Interleukin 1 beta (IL-1 beta) increases the release of corticotropin-releasing factor (CRF) in the brain through prostaglandin pathways. Because central CRF inhibits gastric motor function, the influence and mechanism of action of intracisternal injection of IL-1 beta on gastric emptying were investigated.
The 20-minute rate of gastric emptying of a nonnutrient test meal was assessed by the phenol red methylcellulose method 30 minutes after injection of human recombinant IL-1 beta in conscious rats.
IL-1 beta injected intracisternally (0.01-1 ng) or intravenously (0.01-10 ng) dose-dependently decreased gastric emptying by 10%-82% and 0%-89%, respectively. The median effective dose (ED50) was 30-fold lower when IL-1 beta was injected intracisternally (0.1 ng) than intravenously (3 ng). The inhibitory effect of intracisternal IL-1 beta had a rapid onset (within 20 minutes) and was long-lasting (6 hours). Indomethacin (5 mg/kg, intraperitoneally) completely prevented the 61% inhibition induced by intracisternal IL-1 beta (0.1 ng) but had no effect on CRF-induced (600 ng) 72% inhibition of gastric emptying. The intracisternal injection of the IL-1 receptor antagonist (100 ng) or the CRF antagonist [DPhe12, [DPhe12,Nle21,38,C alpha MeLeu37]CRF12-41 (20 micrograms) prevented by 100% and 52%, respectively, the inhibition of gastric emptying evoked by intracisternal IL-1 beta (0.1 ng). The antagonists alone had no effect on basal gastric emptying.
IL-1 beta acts in the brain to induce a long-lasting inhibition of gastric emptying; IL-1 beta action is mediated through central IL-1 receptors and prostaglandin- and CRF-dependent mechanisms.
背景/目的:白细胞介素1β(IL-1β)通过前列腺素途径增加大脑中促肾上腺皮质激素释放因子(CRF)的释放。由于中枢CRF抑制胃运动功能,因此研究了脑池内注射IL-1β对胃排空的影响及其作用机制。
在清醒大鼠中注射人重组IL-1β 30分钟后,采用酚红甲基纤维素法评估非营养性试验餐20分钟的胃排空率。
脑池内注射(0.01 - 1 ng)或静脉注射(0.01 - 10 ng)IL-1β分别以剂量依赖方式使胃排空减少10% - 82%和0% - 89%。脑池内注射IL-1β(0.1 ng)时的半数有效剂量(ED50)比静脉注射(3 ng)低30倍。脑池内IL-1β的抑制作用起效迅速(20分钟内)且持续时间长(6小时)。吲哚美辛(5 mg/kg,腹腔注射)完全阻止了脑池内IL-1β(0.1 ng)诱导的61%的抑制作用,但对CRF诱导的(600 ng)胃排空72%的抑制作用无影响。脑池内注射IL-1受体拮抗剂(100 ng)或CRF拮抗剂[DPhe12,[DPhe12,Nle21,38,CαMeLeu37]CRF12 - 41(20 μg)分别100%和52%地阻止了脑池内IL-1β(0.1 ng)引起的胃排空抑制。单独使用拮抗剂对基础胃排空无影响。
IL-1β在大脑中发挥作用,诱导对胃排空的长期抑制;IL-1β的作用通过中枢IL-1受体以及前列腺素和CRF依赖性机制介导。